CORMORANT ASSET MANAGEMENT, LLC Information

100 HIGH STREET, SUITE 1105, BOSTON, Massachusetts, 02110, (617) 848-3429

Report Date: 09/30/2014

Position Statistics

Total Positions 68
New Positions 16
Increased Positions 24
Decreased Positions 13
Positions with Activity 37
Sold Out Positions 4
Total Mkt Value (in $ millions) 600

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 17.31%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 59.12%
Services
Technology
Transportation
Utilities

24 INCREASED Positions as of 09/30/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
PUMA BIOTECHNOLOGY INC COM 96,841 57,246 144.58 507,500
RECEPTOS INC COM 94,194 33,956 56.37 748,700
OVASCIENCE INC COM 23,306 23,306 New 516,200
NEUROCRINE BIOSCIENCES INC COM 19,355 12,524 183.33 850,000
ACCELERON PHARMA INC COM 16,200 8,100 100 400,000
KERYX BIOPHARMACEUTICALS INC COM 14,230 14,230 New 1,000,000
AGIOS PHARMACEUTICALS INC COM 11,443 11,443 New 100,000
SYNAGEVA BIOPHARMA CORP COM 9,128 9,128 New 100,000
BRISTOL MYERS SQUIBB CO COM 8,937 8,937 New 150,000
ARDELYX INC COM 8,334 8,334 New 388,700
IMMUNE DESIGN CORP COM 7,230 7,230 New 200,000
ACELRX PHARMACEUTICALS INC COM 6,920 2,076 42.86 1,000,000
NEKTAR THERAPEUTICS COM 6,851 6,851 New 450,000
KITE PHARMA INC COM 5,403 5,403 New 100,000
AVALANCHE BIOTECHNOLOGIES INC COM 3,162 3,162 New 65,000
ADVAXIS INC COM NEW 2,790 2,790 New 350,000
KINDRED BIOSCIENCES INC COM 2,405 1,718 250 350,000
ZS PHARMA INC COM 2,181 2,181 New 50,000
RECRO PHARMA INC COM 2,072 592 40 700,000
CELLECTAR BIOSCIENCES INC COM NEW 1,680 1,680 New 530,000


Latest News Headlines

View All
Create your free portfolio